Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06013514

Post-market Prospective Clinical Study of Nagor Perle Mammary Implants

A Prospective, Multi-center, Observational, Non Comparative, Post-marketing Surveillance Study to Obtain Clinical Outcome Data on the Nagor PERLE Range of Silicone Breast Implants When Used in Breast Implantation

Status
Recruiting
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
GCA (Eurosilicone) · Industry
Sex
Female
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Patients can undergo breast implant surgery for multiple reasons; cosmetic and reconstructive being the primary indications. In order to confidently state safety and due to strict regulation on medical devices it is important to maintain a record of safety and performance with all medical implants. This study is designed to collect data on a new generation of smooth mammary implants to assess the long term performance and safety data on this type of gel-filled mammary breast implant. The two main complications of breast implants are capsular contracture and rupture; these complications can take years to develop. The study is designed to evaluate the occurrence of these two primary complication as well as other secondary complications over a period of 10 years. Patient follow up will be carried out pre-operatively and post operatively at 12 months and then 3, 5, 8 and 10 years thereafter. The study will be carried out over 10 years to adequately assess complications which may only occur over the lifetime of the device such as systemic complications

Conditions

Interventions

TypeNameDescription
DEVICEPERLE Sterile Smooth Opaque gel filled mammary implantsSterile smooth opaque gel filled mammary implants will be implanted in adult women having breast surgery for either augmentation, reconstruction or revision surgery. Different ranges of implants will be used to suit patient needs

Timeline

Start date
2024-06-01
Primary completion
2038-09-01
Completion
2038-09-01
First posted
2023-08-28
Last updated
2025-07-11

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT06013514. Inclusion in this directory is not an endorsement.